Scorpion Sinks Pincers Into Funding Round For PI3K Inhibitor
The oncology-focused start-up announced it closed a $150m series C financing that it plans to use to advance STX-478.
The oncology-focused start-up announced it closed a $150m series C financing that it plans to use to advance STX-478.